Medicines that cannot be parallel exported from the UK

Medicines that cannot be parallel exported from the UK

On 3rd October 2019 The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) issued a list of medicines which must not be parallel exported from the UK. This action has been taken to ensure the continued supply of medicines to meet the needs of UK patients.

DHSC and the MHRA have written to medicine manufacturers and wholesalers to remind them of their responsibilities to ensure the continued supply of medicines to meet the needs of UK patients. The letter also includes the list of medicinal products which “cannot be supplied for parallel export or parallel distribution from the UK or hoarded (held back)” for the time being.

The list (see below), which will be reviewed on an ongoing basis, contains any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.
Generic name Strength Pharmaceutical form Date of restriction
Colestyramine any sachets 05/12/2019 00:00
Fluticasone proprionate any nasules 05/12/2019 00:00
Hepatitis A and B vaccine any any 14/11/2019 00:00
Alogliptin/ metformin any tablet 06/11/2019 00:00
Measles, Mumps and Rubella vaccine any any 06/11/2019 00:00
Misoprostol any tablet 06/11/2019 00:00
Pneumococcal Polysaccharide vaccine any any 06/11/2019 00:00
Alprostadil any any 18/10/2019 00:00
Beclometasone dipropionate (QVAR) any inhaler 18/10/2019 00:00
Norethisterone any any 18/10/2019 00:00
Ranitidine any any 18/10/2019 00:00
Adrenaline any auto-injector 04/10/2019 00:00
Conjugated oestrogen any any 04/10/2019 00:00
Conjugated oestrogen/ bazedoxifene any any 04/10/2019 00:00
Conjugated oestrogen/ medroxyprogesterone any any 04/10/2019 00:00
Estradiol any any 04/10/2019 00:00
Estradiol hemihydrate any any 04/10/2019 00:00
Estradiol hemihydrate/ dydrogesterone any any 04/10/2019 00:00
Estradiol hemihydrate/ levonorgestrel any any 04/10/2019 00:00
Estradiol hemihydrate/ norethisterone acetate any any 04/10/2019 00:00
Estradiol valerate any any 04/10/2019 00:00
Estradiol valerate/ medroxyprogesterone any any 04/10/2019 00:00
Estradiol/ norethisterone acetate any any 04/10/2019 00:00
Estradiol/ norgestrel any any 04/10/2019 00:00
Estriol any any 04/10/2019 00:00
Hepatitis B vaccine any any 04/10/2019 00:00
Levonorgestrel any any 04/10/2019 00:00
Medroxyprogesterone any any 04/10/2019 00:00
Oseltamivir any any 04/10/2019 00:00
Ospemifene any any 04/10/2019 00:00
Prazosin any tablet 04/10/2019 00:00
Progesterone any any 04/10/2019 00:00
Rivaroxaban any tablet 04/10/2019 00:00
Tibolone any any 04/10/2019 00:00

Read the DHSC/MHRA letter to holders of a wholesale dealer licence

Any manufacturer or wholesaler found parallel exporting one or more of these medicines could face the immediate suspension of their wholesaler dealer licence.

View the gov.uk page here.



Latest Dispensing and Supply news

View more Dispensing and Supply news >